StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | UTHR United Therapeutics | $575.79 | -0.65% | $24.1B | 18.8 | 7.6 | +5.9% | 86.6% | 51 |
| 1 | BIIB Biogen | $191.37 | -6.43% | $28.4B | 20.7 | 2.9 | +1.2% | 75.5% | 78 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $196.91 |
| +0.81% |
| $28.3B |
| — |
| 11.3 |
| +36.6% |
| 65.1% |
| 60 |
| 3 | MRNA Moderna | $50.03 | -0.77% | $20.0B | — | 9.0 | -30.0% | 35.0% | 54 |
| 4 | ALNY Alnylam Pharmaceuticals | $293.45 | +0.68% | $38.5B | 66.7 | 9.0 | +82.6% | 80.8% | 52 |
| 5 | NBIX Neurocrine Biosciences | $159.05 | -1.41% | $16.1B | 24.1 | 5.2 | +28.6% | 98.2% | 47 |
| 6 | INCY Incyte | $97.63 | -1.20% | $19.5B | 13.7 | 3.6 | +21.5% | 93.0% | 44 |
| 7 | INSM Insmed | $115.62 | -2.01% | $25.4B | — | 31.0 | +115.1% | 81.8% | 41 |
| 8 | RVMD RVMD | $149.47 | -0.31% | $31.9B | — | 2754.6 | — | — | — |
| 9 | SMMT SMMT | $18.14 | -3.46% | $14.6B | — | 15191.8 | — | — | — |